Publications by authors named "Pere Santamaria"

115Publications

Reversal of autoimmunity by mixed chimerism enables reactivation of β cells and transdifferentiation of α cells in diabetic NOD mice.

Proc Natl Acad Sci U S A 2020 12 23;117(49):31219-31230. Epub 2020 Nov 23.

Diabetes and Metabolism Research Institute, The Beckman Research Institute of City of Hope, Duarte, CA 91010;

View Article and Find Full Text PDF
December 2020

Ubiquitous antigen-specific T regulatory type 1 cells variably suppress hepatic and extrahepatic autoimmunity.

J Clin Invest 2020 04;130(4):1823-1829

Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Alberta, Canada.

View Article and Find Full Text PDF
April 2020

Suppression of a broad spectrum of liver autoimmune pathologies by single peptide-MHC-based nanomedicines.

Nat Commun 2019 05 14;10(1):2150. Epub 2019 May 14.

Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB, T2N 4N1, Canada.

View Article and Find Full Text PDF
May 2019

Antigen-specific therapeutic approaches for autoimmunity.

Nat Biotechnol 2019 03 25;37(3):238-251. Epub 2019 Feb 25.

Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

View Article and Find Full Text PDF
March 2019

Taming autoimmunity: Translating antigen-specific approaches to induce immune tolerance.

J Exp Med 2019 02 16;216(2):247-250. Epub 2019 Jan 16.

Julia McFarlane Diabetes Research Centre and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada

View Article and Find Full Text PDF
February 2019

Nanoparticles for Immune Stimulation Against Infection, Cancer, and Autoimmunity.

ACS Nano 2018 11 15;12(11):10621-10635. Epub 2018 Oct 15.

Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine , University of Calgary , Calgary , Alberta T2N 4N1 , Canada.

View Article and Find Full Text PDF
November 2018

Nanoparticle-based approaches to immune tolerance for the treatment of autoimmune diseases.

Eur J Immunol 2018 05 26;48(5):751-756. Epub 2018 Feb 26.

Institut D'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.

View Article and Find Full Text PDF
May 2018

A Gut Microbial Mimic that Hijacks Diabetogenic Autoreactivity to Suppress Colitis.

Cell 2017 Oct;171(3):655-667.e17

Julia McFarlane Diabetes Research Centre (JMDRC), University of Calgary, Calgary AB T2N 4N1, Canada; Autoimmunity Research Group, Institut D'Investigacions Biomèdiques August Pi i Sunyer, 08036 Barcelona, Spain; Department of Microbiology, Immunology, and Infectious Diseases, Snyder Institute for Chronic Diseases, University of Calgary, Calgary AB T2N 4N1, Canada. Electronic address:

View Article and Find Full Text PDF
October 2017

Peptide-MHC-based nanomedicines for autoimmunity function as T-cell receptor microclustering devices.

Nat Nanotechnol 2017 07 24;12(7):701-710. Epub 2017 Apr 24.

Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.

View Article and Find Full Text PDF
July 2017

Expanding antigen-specific regulatory networks to treat autoimmunity.

Nature 2016 Feb 17;530(7591):434-40. Epub 2016 Feb 17.

Julia McFarlane Diabetes Research Centre (JMDRC), and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada.

View Article and Find Full Text PDF
February 2016

E2-2 Dependent Plasmacytoid Dendritic Cells Control Autoimmune Diabetes.

PLoS One 2015 1;10(12):e0144090. Epub 2015 Dec 1.

Department of Immunology and Microbiology, University of Copenhagen, Copehagen, Denmark.

View Article and Find Full Text PDF
June 2016

Prolactin as an Adjunct for Type 1 Diabetes Immunotherapy.

Endocrinology 2016 Jan 29;157(1):150-65. Epub 2015 Oct 29.

Department of Biochemistry and Molecular Biology (C.M.H., V.S., C.H.), Alberta Children's Hospital Research Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1; Julia McFarlane Diabetes Research Centre and Department of Microbiology, Immunology and Infectious Diseases (S.T., P.S.), Snyder Institute for Chronic Diseases, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1; Institut D'Investigacions Biomediques August Pi i Sunyer (P.S.), 08036 Barcelona, Spain; and Department of Pediatrics (C.H.), Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada T2N 4N1.

View Article and Find Full Text PDF
January 2016

Nanoparticle-based autoimmune disease therapy.

Clin Immunol 2015 Sep 19;160(1):3-13. Epub 2015 Feb 19.

Institut D'Investigacions Biomediques August Pi i Sunyer, Barcelona 08036, Spain; Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cummings School of Medicine, University of Calgary, Calgary, Alberta T2N 4N1, Canada. Electronic address:

View Article and Find Full Text PDF
September 2015

Nanoparticle-based immunotherapy for cancer.

ACS Nano 2015 Jan 23;9(1):16-30. Epub 2014 Dec 23.

Julia McFarlane Diabetes Research Centre (JMDRC) and Department of Microbiology, Immunology and Infectious Diseases, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, Cummings School of Medicine, University of Calgary , Calgary, Alberta T2N 4N1 Canada.

View Article and Find Full Text PDF
January 2015